By Jilian Mincer MORGANTOWN, West Virginia (Reuters) – A shortage of nurses at U.S. hospitals hit West Virginia’s Charleston Area Medical Center at the worst possible time. The non-profit healthcare system is one of the state’s largest employers and sits in the heart of economically depressed coal country. It faces a $40 million deficit this […]
Read More
TOKYO (Reuters) – Japanese trading house Mitsubishi Corp <8058.T> plans to set up a joint venture with U.S. data center operator Digital Realty Trust <DLR.N> and build around 10 data centers in Japan by 2022 for 200 billion yen ($1.8 billion), the Nikkei said on Saturday. Tokyo-based Mitsubishi expects the centers to help meet growing […]
Read More
By Tina Bellon and Nate Raymond (Reuters) – A California judge on Friday threw out a $417 million verdict against Johnson & Johnson <JNJ.N> in a lawsuit by a woman who claimed she developed ovarian cancer after using its talc-based products like Johnson’s Baby Powder for feminine hygiene. The ruling by Los Angeles Superior Court […]
Read More
By Stephanie Nebehay and Kate Kelland GENEVA/LONDON (Reuters) – The World Health Organization (WHO) should overturn its decision to appoint Zimbabwean President Robert Mugabe as a goodwill ambassador, global health leaders said on Saturday, describing the move as unjustifiable and wrong. Britain said Mugabe’s appointment was “surprising and disappointing” and added that it risked overshadowing […]
Read More
(Corrects to clarify attribution in second paragraph in this Oct. 20 story) By Fergus Jensen JAKARTA (Reuters) – Asia Pacific Resources International Limited (APRIL) has suspended forestry operations at its Indonesian pulp and paper subsidiary after the government canceled a long-term work plan citing environmental non-compliance. PT Riau Andalan Pulp and Paper’s (RAPP) work plan […]
Read More
TENBY, Wales (Reuters) – Storm Brian battered towns in Ireland and along the western coast of England and Wales on Saturday, with gusts and high seas causing heavy damage to buildings. Less than a week after Tropical Storm Ophelia killed three people, Ireland’s weather office issued an warning that winds were likely to average 55 […]
Read More
BEIJING (Reuters) – The economic impact of China’s tough campaign against smog this winter is expected to be limited, a senior state planning official said on Saturday. “Measures to fight pollution don’t have a big impact on economic growth,” Zhang Yong, vice-chairman of the National Development and Reform Commission, told reporters during a briefing. As […]
Read More TOKYO (Reuters) – Heavy rain and powerful winds are expected to lash large areas of Japan on Sunday as a strong typhoon sweeps ashore, possibly hindering voter turnout in a national election. Typhoon Lan was classified as an intense Category 4 storm on Saturday, with winds of up to 250 km/h (156 mph), according to […]
Read More
LIMA (Reuters) – Peru’s conservative Congress passed a bill to legalize medical marijuana late on Thursday with a 68-5 vote in favor of allowing cannabis oil to be produced, imported and commercialized. President Pedro Pablo Kuczynski had proposed the measure after police cracked down on a group of mothers making cannabis oil in a makeshift […]
Read More
By David Shepardson (Reuters) – Experimental communications balloons provided by Alphabet Inc in collaboration with AT&T Inc will allow some of the carrier’s customers in storm-ravaged Puerto Rico to send texts and access critical information on the internet, Alphabet said on Friday. Alphabet said the “Project Loon” balloon project would deliver limited internet connectivity to […]
Read More
By Tom Polansek CHICAGO (Reuters) – Monsanto Co sued Arkansas agricultural officials on Friday to stop a proposed summer ban on a weed killer linked to widespread crop damage beyond the major farm state’s borders. The lawsuit seeks to block the Arkansas State Plant Board from prohibiting the use of dicamba herbicides, manufactured by Monsanto […]
Read More
(Reuters) – The U.S. Food and Drug Administration approved GlaxoSmithKline’s Shingrix shingles vaccine for use in adults aged 50 and over, a move widely expected after an advisory panel to the agency last month voted unanimously to recommend its approval, the company announced on Friday. Shingrix is seen as an improvement over Zostavax, the only […]
Read More
